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Background:  The degree of reversibility of pulmonary hypertension (PH) in mitral stenosis (MS) impacts surgical outcome and its pre-op 
assessment is the key in risk stratification.
case:  A 68 year old woman presented with 2 weeks of dyspnea. Her medical history included atrial fibrillation, Sjogren’s syndrome and 
rheumatic heart disease with moderate MS. On physical examination there was neck vein distension, peripheral edema, a 2/6 systolic 
murmur and 1/6 diastolic murmur. She received diuretics, improved and was admitted for further work up.
decision Making:  Echocardiography demonstrated severe MS (valve area of 1.2 cm2) with moderate mitral regurgitation (MR), severe 
tricuspid regurgitation and severe PH. The right ventricle (RV) was dilated and hypokinetic but left ventricular systolic function was 
preserved. Because the severity of PH may have been out of proportion to the severity of MS she underwent cardiac catheterization to 
assess the PH reversibility. Her hemodynamic data are shown in the table. Importantly nitric oxide did not reduce her PH which may have 
been related to Sjogren’s syndrome. Because her mean transmitral gradient was only 7 mm Hg, it was unlikely that high risk surgical relief 
of her MS would have alleviated her RV pressure overload. Her Wilkins score of 12 and 2+ MR also made successful balloon valvuloplasty 
unlikely.
conclusion:  Pre-op recognition of severe fixed PH made it unlikely that the patient would benefit from mitral valve surgery.
Parameters Baseline After Nitric Oxide Administration
Pulmonary artery saturation (%) 60.4 65
Femoral artery saturation (%) 97.6 97.9
Hemoglobin (Gm/dl) 13 12.8
A-V O2 difference 64.8 56.4
Pulmonary artery pressure (mmHg) 98/42/60 89/42/57
